Sign in
Explore the registryTrack Flu mrna's trials

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Flu mRNA (Formulation B1)OngoingActive not recruitingPhase 2Open NCT07204964 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…